Abstract. Discovery and development of new pharmaceuticals from marine organisms are attracting increasing interest. Several agents derived from marine organisms are under preclinical and clinical evaluation as potential anticancer drugs. We extracted and purified a novel anti-tumor protein from the coelomic fluid of Meretrix meretrix Linnaeus by ammonium sulphate fractionation, ion exchange and hydrophobic interaction chromatography. The molecular weight of the highly purified protein, designated MML, was 40 kDa as determined by SDS-PAGE analysis. MML exhibited significant cytotoxicity to several cancer cell types, including human hepatoma BEL-7402, human breast cancer MCF-7 and human colon cancer HCT116 cells. However, no inhibitory effect was found when treating murine normal fibroblasts NIH3T3 and benign human breast MCF-10A cells with MML. The cell death induced by MML was characterized by cell morphological changes. The induction of apoptosis of BEL-7402 cells by MML was weak by DNA ladder assay. The possible mechanisms of its anti-tumor effect might be the changes in cell membrane permeability and inhibition of tubulin polymerization. MML may be developed as a novel, highly selective and effective anti-cancer drug.
Introduction
Marine organisms represent an essentially unexploited reservoir for discovery and development of potential products of genetic, biological and/or pharmacological interest, in particular for anti-cancer drugs (1) (2) (3) (4) . Some natural products derived from marine organisms are evaluated and developed in preclinical and/or clinical status as potential anti-cancer drugs and these kinds of products are dominated by lowmolecular-weight compounds so far (4) . However, a few macromolecular compounds with anti-tumor activity have also been reported. For example, Aplysianins (5-7), Julianins (8, 9) and Dolabellanins (10-13) are all glycoproteins isolated from different tissues of sea hare and they can inhibit the proliferation of multiple tumor cells and cause tumor lysis (5) (6) (7) (8) (9) (10) (11) (12) (13) . Cyplasin is a 56 kDa cytotoxic protein isolated from the mucus of European sea hare Aplysia punctata and it shows preferential toxicity to autonomously growing transformed mammalian cells (4) . Previous study from our laboratory confirmed that a novel polypeptide PG155 from shark cartilage showed potent anti-angiogenic activity by inhibiting vascular migration and tubulogenesis of human umbilical vein endothelial cells induced by vascular endothelial growth factor (VEGF). Further study revealed that PG155 could significantly inhibit angiogenesis of zebrafish embryos in vivo (14) .
Meretrix meretrix Linnaeus has long been used as traditional Chinese medicine for the treatment of various cancers and other diseases. There is evidence to show that M. meretrix has anti-cancer efficacy, eliminating cysts and detoxification (15) (16) (17) (18) . Several peptides and proteins with antitumor activity have also been extracted from M. meretrix. Leng et al purified a peptide from M. meretrix, which exhibited strongly inhibitory effect on the growth of human stomach adenocarcinoma BGC-823 cells (18) . In addition, two glycoproteins, MGP0405 (MW: 9,655 Da) and MGP0501 (MW: 15,878 Da), were reported to have anti-tumor effect in vitro (19, 20) .
In the present studies, we extracted and purified a novel protein with potent anti-tumor activity from the coelomic fluid of M. meretrix. The effects of this protein on cell growth inhibition and morphological alterations were evaluated on several human cancer cell types. In order to find the possible mechanisms of the anti-tumor activity of MML, we investigated its effects on the changes of cell membrane permeability by SEM observation, Hoechst 33342/PI dual staining and LDH leakage assays. We also studied the effect of MML on the inhibition of tubulin polymerization by tubulin immunofluorescence staining. DNA ladder assay was employed to study apoptosis induced by MML in BEL-7402 cells. Procedures for extraction and purification. The fluids were collected from the cavity of M. meretrix by splitting the shells open and they were centrifuged at 8,000 x g for 30 min to remove the precipitates. Ammonium sulphate powder was slowly added to the supernatants to reach a saturation of 40%. After centrifugation at 12,000 x g for 30 min, the supernatants were collected and additional ammonium salt was added to reach 60% saturation. The precipitates were collected by centrifugation at 12,000 x g for 30 min, dialyzed against 0.05 M, pH 6.0 sodium acetate buffer, applied to a CMcellulose-52 column and eluted with the same buffer containing 0.08 M, 0.3 M and 1 M sodium chloride.
Materials and methods

Materials
All of the fractions were collected and analyzed their cytotoxicity by MTT assay. The active fractions were dialyzed against 0.05 M sodium acetate buffer, pH 6.0 containing 2.2 M sodium chloride. Then the supernatants were loaded to a Phenyl Sepharose FF column. The column was washed with the starting buffer and eluted with 1 M sodium chloride, H 2 O and 5% ethylene glycol, respectively. The active fractions were pooled and dialyzed against 0.02 M Tris buffer, pH 7.8. The supernatants were applied to a REsource15Q column on FPLC (GE, USA). Elution was performed with the same buffer containing 0.1 M and 0.5 M sodium chloride. The protein concentrations of each fraction were determined by using the BCA protein assay kit (Pierce, USA).
SDS-polyacrylamide gel electrophoresis. SDS-polyacrylamide gel electrophoresis was performed to determine the purity of isolated proteins according to the method described by Laemmli (21) . Purified protein (0.1 μg) was used in the analysis. Electrophoresis of protein was carried out on 12% polyacrylamide gel stained with Coomassie brilliant blue R250.
Assessment of cytotoxicity.
The inhibitory effects of the antitumor protein on the growth of cancer cells as well as benign cells NIH3T3 and MCF-10A were assessed in vitro by MTT assay (22) . Five thousand cells per well were seeded in a 96-well microplate. Cells were cultured in 180 μl media of RPMI-1640 or DMEM for 24 h. The purified protein with different concentrations was added to the medium. After 48 h, MTT solution (100 μl, 0.5 mg/ml) was added into each well and the cells were incubated for another 4 h. After adding 150 μl DMSO to each aspirated well, the plate was gently agitated until the color reaction was uniform. The OD 570 was determined by a microplate reader (Bio-Tek Instruments, USA) with subtraction of background absorbance.
Morphological alterations of BEL-7402 cells.
Morphological alterations of BEL-7402 cells after MML treatment were investigated using phase contrast microscopy and SEM. The cells were seeded and cultured in 96-well plates, as described above. After incubation with 52.2 μg/ml MML, the morphology of cells was observed under the CKX41 phase contrast microscopy (Olympus, Japan) and photographed at 30, 60, 90 and 120 min, respectively. In the SEM experiment, BEL-7402 cells were grown onto poly-L-lysine-coated coverslips in 6-well plates for 24 h to allow firm attachment. Then they were treated with 52.2 μg/ml MML and incubated for 60 min. The medium containing MML was removed and subsequently the cells were fixed in glutaraldehyde. After fixation overnight at 4˚C, the coverlips were dehydrated in ethanol and dried in a critical point dryer. Cells on coverslips were coated with gold and analyzed by the S-3400N SEM (Hitachi, Japan).
Hoechst 33342/PI dual staining. The BEL-7402 cells were seeded in 6-well plates at 5x10 4 per well and treated with 52.2 μg/ml MML. After incubation for 24 h, the cells were collected into a 1.5 ml Eppendorf tube, centrifuged at 1,000 x g for 5 min to remove the medium and then stained with Hoechst 33342 and PI by using the dual staining Kit (Beyond, China). The cells were spread on slides and observed under the fluorescence microscopy (Zeiss, Germany).
LDH leakage assay. LDH leakage assay was performed to determine the membrane damage and loss of membrane integrity. The cells were seeded and cultured in 96-well plates, as described above. After incubation with various concentrations (26.1, 52.2, 104.4 μg/ml) of MML for 24 h, the activity of LDH in the medium supernatants(S) and remaining cells (C) was analyzed using the Colorimetric LDH cytotoxicity assay kit (Promega, USA). The percentage of LDH leakage was calculated as follows, leakage (%) = S/(S + C) x 100%.
Cell cycle analysis. BEL-7402 cells were seeded at 3x10 4 /cm 2 in 10-cm dishes and treated with 52.2 μg/ml MML. After incubation for 24 h, the cells were collected and washed with PBS for three times and then were resuspended in 5 μg/ml PI (1 ml) containing 100 U/ml RNase A. The DNAs of cells were stained by PI, while the RNAs were removed by digestion with RNase A at 4˚C for 30 min. The DNA contents of the cells were determined by FACSCalibur™ cytometer (Becton-Dickinson, Germany).
Indirect immunofluorescence detection of ·-tubulin. BEL-7402 cells were grown onto glass coverslips in 6-well dishes. After incubation for 24 h, the cells were exposed to 52.2 μg/ml MML for 30 min. Then the cells were fixed with 2% paraformaldehyde for 10 min at room temperature. After washing twice with PBS, the cells were blocked with PBS/FBS solution for 20 min and then incubated with mouse monoclonal anti-·-tubulin antibody (1:500, Calbiochem, USA) in 0.1% Triton/ PBS/FBS solution for 60 min at room temperature in a humidified chamber. After washing twice with PBS/FBS solution, the cells were incubated with a second antibody (FITC-anti-mouse IgG, 1:500, Calbiochem) in the dark for 60 min at room temperature, washed again with PBS/FBS solution and covered with a glass slide. Cellular microtubules were observed under fluorescence microscopy (Zeiss, Germany).
DNA ladder assay. BEL-7402 cells were seeded at 3x10
4 /cm 2 in 10-cm dishes and incubated for 24 h. After treated with 52.2 μg/ml MML for 48 h, the cells were collected and total genomic DNA was extracted according to the protocol described in Universal Genomic DNA extraction kit (Takara, Japan). The DNA samples were resolved on 1.0% agarose gel stained with 0.5 μg/ml of ethidium bromide and photographed by Quantity one system (Bio-Rad, USA).
Results
Extraction and purification of the protein from Meretrix meretrix. The protein was extracted and purified from the coelomic fluid by ammonium sulphate fractionation, ion exchange and hydrophobic interaction chromatography. The elution profiles on column chromatography are shown in Fig. 1 . The precipitates formed at 40-60% ammonium sulphate saturation were applied to a CM-cellulose-52 column. The active fractions were eluted with 0.08 M sodium chloride solution (Fig. 1A) and further purified by Phenyl Sepharose FF (Fig. 1B) . After hydrophobic chromatography, the active components were applied to a REsource-15Q pre-packed column eluted with 0.1 M sodium chloride solution, and purified to homogeneity (Fig. 1C) . The purified protein, designated MML, revealed as a single band of 40 kDa on SDS-polyacrylamide gel electrophoresis (Fig. 1D) .
Cytotoxicity of MML against human cancer cells. During the purification process, MTT colorimetric method was employed to trace the active components for cell growth inhibition against human hepatoma BEL-7402 cells. The purified protein, MML, significantly inhibited the growth of BEL-7402 cells and the IC 50 was determined to be 52.2 μg/ml (Fig. 2) . MML displayed cytotoxicity also to human breast cancer MCF-7 and human colon cancer HCT116 cells. However, it had no inhibitory effect on the growth of benign cells, including murine fibroblasts NIH3T3 as well as human breast epithelial cell line MCF-10A at a concentration of 80 μg/ml (Fig. 2) . Moreover, no growth inhibition of NIH3T3 and MCF-10A cells was found while increasing the concentration of MML to 300 μg/ml (data not shown). 
MML induces the morphological alterations of BEL-7402 cells.
Remarkable alterations of cell membrane of BEL-7402 cells were observed after MML treatment. The architecture of untreated BEL-7402 cells displayed a typical spindle shape (Fig. 3A) . However, the morphology of the cells started to change in a short time after incubation with MML. The cells detached from the substratum, became rounding (Fig. 3B ) and separated from each other (Fig. 3C ) after exposure to MML for 30-60 min. Membrane bulge and detachment from cytoplasmic inclusion were observed in 90 min after MML treatment (Fig. 3D) . Obvious bulging of the membranes was found when treated with MML for 120 min (data not shown).
The morphologic changes of the cell membrane were also clearly visualized by SEM. The untreated BEL-7402 cells showed a normal smooth surface (Fig. 3E) . In contrast, the cells treated with MML became rounded and the surface of the cell membrane was markedly disrupted (Fig. 3F) .
MML increases the permeability of cell membrane of BEL-7402 cells.
To demonstrate the effects of MML on cell permeability of BEL-7402 cells, Hoechst 33342/PI dual staining and LDH leakage assay were performed. The BEL-7402 cells displayed integrate cell membranes and did not stain by PI without MML treatment (Fig. 4A) . In contrast, typical red fluorescence of PI in the BEL-7402 cells was visible after MML treatment (Fig. 4B) . The results demonstrated that MML increased the membrane permeability of BEL-7402 cells. Furthermore, the percentage of LDH leakage was significantly increased (P<0.01) in BEL-7402 cells treated with MML compared to that of untreated cells (Fig. 4C) . The increase of LDH activity was in a dose-dependent manner and more LDH leakage was observed with higher MML concentrations (Fig. 4C ).
MML induces cell cycle arrest in G2/M phase and inhibits tubulin polymerization.
To further evaluate the mode of action of MML, the effects of MML on the location of BEL-7402 cells in the cell cycle were examined by using flow cytometry analysis. The result showed that MML blocked BEL-7402 cells in G2/M phase in a dose-dependent manner (Fig. 5) . Since microtubule-targeted anti-cancer agents arrested cell cycle in G2/M phase, we examined the microtubule network of BEL-7402 cells treated with MML by indirect immuno-fluorescence approach. The result of MML affecting tubulin polymerization is shown in Fig. 6 . The microtubule network in untreated cells showed normal organization (Fig. 6A ) while tubulin polymerization was inhibited in treated cells (Fig. 6B) .
DNA ladder assay.
To further understand the molecular events underlining the MML on cancer cells, DNA ladder assay was performed to study MML inducing apoptosis. As shown in Fig. 7 , BEL-7402 cells treated with VP16 (positive control) were characterized by fragmentation of DNA (DNA ladder) on the agarose gel. Electrophoresis of DNA from the cells treated with MML also displayed DNA ladders, but the fragmentation was much weaker than that of the VP16-treated cells.
Discussion
In the present study, we extracted and purified a novel antitumor protein from the coelomic fluid of Meretrix meretrix Linnaeus. MTT assay indicated that purified MML could selectively inhibit the proliferation of several human cancer cells. Treatment of human hepatoma BEL-7402 cells with MML resulted in increased permeability of cell membrane and inhibition of tubulin polymerization. An interesting point in our study was that the novel protein, MML, displayed potent cytotoxicity to human hepatoma BEL-7402 cells. Also, MML could inhibit the growth of human breast cancer MCF-7 and human colon cancer HCT116 (27). It was found that magainin II could interact strongly with the anionic lipid of cell membranes (28) . However, further study is needed to address if there are differences in the contents of anionic lipid between tumor and benign cells.
There is evidence to show that most of anti-microbial peptides cause cell death by increasing cell membrane permeability. Cecropin A and B, anti-microbial peptides isolated from the hemolymph of giant silk moth Hyalophora cecropia (29) , possessed the ability to form specific amphipathic ·-helices to target non-polar lipid cell membranes (30) (31) (32) . The peptides targeted membrane by forming ionpermeable channels and subsequently resulted in cell depolarization, irreversible cytolysis and finally cell death (33, 34) . Previous studies have demonstrated that both Cecropin A and B family members showed cytolytic activity against various human cancer cell lines, including leukemia, lymphoma and colon carcinoma (23, 35) as well as small cell lung cancer (36), gastric cancer (37) and bladder cancer (38) . Intensive studies have proved that many anti-microbial peptides utilized a unique mechanism to lyse the membrane of cancer cells, either in a 'carpet' model (39) (40) (41) (42) or in a 'barrel-stave' model (40, 43, 44) . Compared with these anti-microbial peptides, MML displayed similar effects against human hepatoma BEL-7402 cells. However, since MML is a macromolecular protein, further studies are required to elucidate the action mode of MML on cancer cell membranes.
Microtubules are the major dynamic structural components in cells and used as the target by several classes of anti-cancer agents. Previous studies with mitotic inhibitors from marine organisms are dominated by the compounds of low-molecularweight. Dolastatin 10, an anti-cancer peptide isolated from the sea hare, could block cells in G2/M phase by inhibiting tubulin polymerization (45) (46) (47) (48) . Our results suggested that MML, likes Dolastatin 10, also induced cell arrest in G2/M phase and the effect might attribute to its inhibition effect on tubulin polymerization. A number of anti-cancer agents could inhibit the tubulin polymerization by direct interaction with tubulin. For example, cryptophycin, vinorelbine and colchicines could bind directly with different sites on tubulin molecule and affect the tubulin polymerization (49) (50) (51) . Further studies are ongoing in our laboratory to investigate if MML interacts with tubulin directly or through receptormediated signal transduction events.
Most anti-cancer agents induce cell death by apoptosis and nuclear fragmentation was a typical indicator for cell apoptosis (52, 53) . In the present study, obvious DNA ladder was observed in the hepatoma cells treated with VP16, while only much weaker DNA fragmentation was presented in the MML-treated cells. Based on this finding, the induction of apoptosis might not be the main effect of MML for its cytotoxicity to human hepatoma cells.
In summary, MML is a novel protein isolated from a marine mollusk with remarkable in vitro anti-tumor activity against cancer cells. MML selectively inhibited the growth of several types of cancer cells. The inhibitory effect of MML on the proliferation of human hepatoma BEL-7402 cells appeared to involve increased cell membrane permeability and damage and inhibition of microtubules polymerization. However, the interaction of this protein with cell membrane and tubulin and the interacting sites on tubulin molecules still require to be further investigated. MML may be a good candidate to be developed as a novel and effective anticancer drug.
